The study of long-term antihypertensive activity of hydrolysate from chicken leg bone protein on spontaneously hypertensive rats

Taiwanese Journal of Agricultural Chemistry and Food Science

Volumn 45, Issue 6, 2007, Pages 310-315

  Cheng, Fu Yuan ^a   Liu, Yu Tse ^a   Wan, Tien Chun ^a   Lai, Kung Ming ^b   Lin, Liang Chuan ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ACE inhibitor; Hydrolysate; Hypertension

Indexed keywords

RATTUS;

EID: 41349103629     PISSN: 16052471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. E. G. Erdos and R. A. Skidgel: The angiotensin I-converting enzyme. Lab. invest., 56: 343-353 (1987).
2. C. I. Johnston, L. M. Burrell, R. Perich, K. Jandeleit and B. Jackson: The tissue renin-angiotensin system and its functional role. Clin. Exp. Pharmacol. Physiol. Suppl, 19: 1-5 (1992).
3. P. Sleight: The rennin-angiotensin system: a review of trials with angiotensin-converting enzyme inhibitors and angiotensin receptor blocking agents. Eur. Heart J. Suppl, 4: 53-57 (2002).
4. M. A. Ondetti, N. J. Williams, E. F. Sabo, J. Pluvec, E. R. Weaver and O. Kocy: Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca: isolation, elucidation of structure and synthesis. Biochemistry, 10: 4033-4042 (1971).
5. M. A. Ondetti, B. Rubin and D. W. Cushman: Design of specific inhibition of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science, 196: 441-444 (1977).
6. M. L. Cohen: Synthetic and fermentation-derived angiotensin converting enzyme inhibitors. Annu. Rev. Pharmacol. Toxicol., 25: 307-323 (1985).
7. J. Brain and R. Rosario: Hypertension: a review and rationale of treatment. Dis. Mon., 51: 548-614 (2005).
8. A. B. Atkinson and J. I. S. Robertson: Captopril in the treatment of clinical hypertension and cardiac failure. Lancet, 2: 836-839 (1979).
9. T. F. T. Antonios and G. A. Macgregor: Angiotensin-converting enzyme-inhibitors in hypertension-potential problems. J. Hypertens., 13: S11-S16 (1995).
10. H. G. Byun and S. K. Kim: Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaska pollack skin. J. Biochem. Mol. Biol, 35: 239-243 (2002).
11. V. Vermeirssen, J. V. Camp and W. Verstraetel: Bio-availability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr., 92: 357-366 (2004).
12. A. Jang and M. Lee: Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci., 69: 653-661 (2005).
13. A. Saiga, T. Okumura, T. Makihara, S. Katsuta, T. Shimizu, R. Yamada and T. Nishimura: Angiotensin I-converting enzyme inhibitory peptides in a hydrolyzed chicken breast muscle extract. J. Agric. Food Chem., 51: 1741-1745 (2003).
14. M. Miguel, I. Recio, J. A. Gómez-Ruiz, M. Ramos and R. López-Fandiño: Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. J. Food Prot., 67: 1914-1920 (2004).
15. M. Miguel, R. López-Fandiño, M. Ramos and A. Aleixandre: Long-term intake of egg white hydrolysate attenuates the development of hypertension in spontaneously hypertensive rats. Life Sci., 78: 2960-2966 (2006).
16. M. Miguel, M. A. Manso, P. J. Martín-Álvarez, A. Aleixandre and R. López-Fandiño: Angiotensin-converting enzyme activity in plasma and tissues of spontaneously hypertensive rats after the short- and long-term intake of hydrolysed egg white. Mol. Nutr. Food Res., 51: 555-563 (2007).
17. R. J. FitzGerald and H. Meisel: Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr., 84: S33-S37 (2000).
18. Chinese source
19. Chinese source
20. D. W. Cushman and H. S. Cheung: Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Phama., 20: 1637-1648 (1971).
21. H. G. Byun and S. K. Kim: Purification and characterization of angiotensin I converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra chalcogramma) skin. Process Biochem., 36: 1155-1162 (2001).
22. W. K. Jung, E. Mendis, J. Y. Je, P. J. Park, B. W. Son, H. C. Kim, Y. K. Choi and S. K. Kim: Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats. Food Chem., 94: 26-32 (2006).
23. C. K. Hyun and H. K. Shin: Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides. Process Biochem., 36: 65-71 (2000).
24. F. Guerard, L. Guimas and A. Binet: Production of tuna waste hydrolysates by a commercial neutral protease preparation. J. Mol. Cata. B: Enzymatic, 19-20: 489-498 (2002).
25. S. K. Kim, H. C. Lee, H. G. Byun and Y. J. Jeon: Isolation and characterization of antioxidative peptides from enzymatic hydrolysates of yellowfin sole skin gelation. J. Kor. Fish. Soc., 29: 246-255 (1996).
26. E. Mendis, N. Rajapakse and S. K. Kim: Antioxidant properties of a radical-scavenging peptide purified from enzymatically prepared fish skin gelatin hydrolysate. J. Agric. Food Chem., 53: 581-587 (2005).
27. Chinese source
28. Chinese source
29. Chinese source
30. J. Wu and X. Ding: Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J. Agric. Food Chem., 49: 501-506 (2001).